SecBot SecBot
Insider Buy ·Filed Jul 31, 2026

ARTV

Artiva Biotherapeutics, Inc.
BULLISH
Impact 7/10
Horizonweeks Processed3mo ago SEC0001231919-26-000817
Insider cluster: 1 insiders, $2.1M total
Actionable Insight ▲ Bullish

This is a strong insider conviction buy from a major shareholder. Traders should watch for upcoming catalysts (e.g., pipeline updates, partnership news) that may have prompted the accumulation. The sustained buying pattern suggests confidence in near-term value.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$10.76
T+0 close · Jul 31, 2026 · via day close
Latest settled
−60.36%
T+60 · $4.27
Vs SPY
−62.14%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 3 $10.76entry
  2. T+1 · 4mo ago +2.88%α +1.08% · $11.07
  3. T+5 · 3mo ago +4.28%α +2.25% · $11.22
  4. T+20 · 3mo ago +5.02%α +3.78% · $11.30
  5. T+60 · 21d ago −60.36%α −62.14% · $4.27
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

RA Capital Management, L.P., a director and 10% owner, purchased $2.05M of ARTV shares in four open-market transactions over eight days (July 22-29, 2026). This represents ~0.79% of the $258M market cap and is a strong insider conviction signal, especially given the firm's sustained buying pattern ($5.0M total insider purchases in the last 30 days).

Key Financial Metrics

Direction
buying
Total Value
$2.0M
Insiders
1

Key Facts

  • RA Capital Management (Director, 10% Owner) bought $2.05M of ARTV shares across 4 trades at ~$9.93-$9.99 per share.
  • Total insider purchases in the last 30 days reached $5.0M across 10 transactions.
  • Purchase represents ~0.79% of ARTV's $258M market cap, a significant proportional stake.
  • Analyst consensus is 92% bullish (4 Strong Buy, 7 Buy, 1 Hold).

Financial Impact

Insider purchase of $2.05M (0.79% of market cap) by a 10% owner.

ownership concentrationmarket sentiment

Risk Factors

  • No specific corporate catalyst disclosed; the buy may reflect long-term positioning rather than imminent news.
  • Biotech sector volatility and clinical-stage risk remain.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001231919-26-000817

Track record

33 reports on ARTV

Performance horizon

10 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +66.32% at T+60 after the Jun 8, 2026 report. 16 of 18 went positive at some point.

Filters
  1. Nov 9, 20267d ago 8-K/A Bearish 7/10 Entry $4.06 Now $3.96 +2.46% settles Dec 9
  2. Nov 3, 202613d ago Insider Cluster Bearish 6/10 Entry $4.22 Now $3.96 +6.16% settles Dec 3
  3. Oct 27, 202620d ago 8-K Bearish 6/10 Entry $4.27 Now $3.96 +7.26% settles Nov 24
  4. Oct 6, 20265w ago 144 Neutral 3/10 Entry $7.00 to $4.21 Now $3.96 −43.43% ▼ −39.93% −38.69% vs SPY
  5. Sep 11, 20269w ago 8-K Neutral 3/10 Entry $10.14 to $6.77 Now $3.96 −60.95% ▼ −33.23% −35.50% vs SPY
  6. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  7. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  8. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  9. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  10. Sep 9, 20269w ago Insider Cluster Bearish 5/10 Entry $10.42 to $6.80 Now $3.96 +62.00% ▲ +34.74% +37.12% vs SPY
Showing 10 of 33

US Market Status

Market Closed · Opens in 5h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 31, 2026